Oct

6

2021

If a patient with deep vein thrombosis (DVT) is not treated with DOAC, what is the preferred next choice of anticoagulant?

By William Aird

A

If a patient with deep vein thrombosis (DVT) is not treated with DOAC, what is the preferred next choice of anticoagulant?

Vitamin K antagonist is preferred over low-molecular weight heparin (LMWH).

2016 ACCP guideline

Stay Updated

If you are interested in getting the latest articles from The Blood Project, enter your name and email

  • This field is for validation purposes and should be left unchanged.